INNATE PHARMA: ifrs:CashFlowsFromUsedInOperatingActivities
| Value | {"amount": -19155000.0} |
|---|---|
| Period | 2022-01-01 – 2022-12-31 |
| Status | superseded |
| Entity | INNATE PHARMA |
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
Retrieved: 2026-08-24T00:10:15.202100+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/c61a0891-a7a2-4acc-aef6-aeffaecbacb5
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
esef:9695002Y8420ZB8HJE29:2023-12-31Retrieved: 2026-08-24T00:10:15.202100+02:00
Raw response sha256:
8cc6e40d8d62bf3f280603498c300fb9…Cite as: FACTANKER, https://factanker.com/fact/c61a0891-a7a2-4acc-aef6-aeffaecbacb5
History
- no predecessors — first report